L

La Beaute Inc.

LABIFiled

La Beaute Inc. · Nasdaq Capital Market · Research source · S-1 · 2026-08-31

Report source
Research source · S-1 · 2026-08-31
SummaryBASIC RESEARCHReport source · S-1

IPO research

La Beaute Inc. has filed a preliminary S-1 to offer 10,000,000 common shares at a fixed price of $5.00 per share, subject to Nasdaq listing approval.

Full source-backed summary

La Beaute Inc. is a newly formed, pre-operating or minimally operating medical-aesthetic platform seeking to raise up to $50 million gross through a 10 million-share IPO at $5.00 per share. The filing contains significant blank financial, dilution, expense, allocation and underwriting information, and the Nasdaq listing is not yet approved.

La Beaute Inc. has filed a preliminary S-1 to offer 10,000,000 common shares at a fixed price of $5.00 per share, subject to Nasdaq listing approval.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointSEC review and possible amendment; Nasdaq listing decision and effectiveness of the registration statement are pending.S-1 · 2026-08-31
Business and development direction

La Beaute Inc.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

The listing application only reserves the ticker and does not assure Nasdaq approval.

Risk 2

The company states that investors may lose their entire investment and that subscription funds generally are non-refundable after acceptance.

Next checkSEC review and possible amendment; Nasdaq listing decision and effectiveness of the registration statement are pending.
Latest filing2026-08-31
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSBookrunners / lead underwriters
PRELIMINARY

The preliminary filing leaves the underwriter appointment or name open.

IPO CAPITAL QUALITY

Fixed offering price per common share $ / share$5.00
Offered common shares Shares10,000,000
Basis and evidence

S-1 · 2026-08-31

La Beaute Inc. has filed a preliminary S-1 to offer 10,000,000 common shares at a fixed price of $5.00 per share, subject to Nasdaq listing approval.

Offering structure

Offering terms
MeasureReported valueUnit
Offered common shares10,000,000Shares
Fixed offering price per common share$5.00$ / share
Source and calculation

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value. Figures retain their stated source scenario and conditions.

Offered common shares

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value.

SEC table 6 row 2 columns 2; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1; vertical offering context cells 1:2,2:2,3:2 ↗

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value. Figures retain their stated source scenario and conditions.

Fixed offering price per common share

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value.

SEC table 6 row 3 columns 2; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1; vertical offering context cells 1:2,2:2,3:2 ↗
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Use of proceedsSource-linked structured inputs are not yet available. Open filing ↗

Dilution and valuation

IPO price$5Price status unverified
Basic post-offer—
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Post-offer common stock — as disclosed210,000,000—
Reported sourcePost-offersharesBasis and evidence 1 ↗
Pre-offer Common stock — as disclosed200,000,000—
Reported sourcePre-offersharesBasis and evidence 2 ↗
Offered common shares10,000,000—
Reported sourcePost-offersharesBasis and evidence 3 ↗
Fixed offering price per common share—$5.00
Reported sourcePrice status unverified$/shareBasis and evidence 3 ↗
Basis and evidence ↗
Basis and evidence 1

Prospectus share summary; Number of shares of common stock outstanding after the offering of common stock; 210,000,000 shares of common stock will be issued and outstanding if we sell all of the shares we are offering, and no shares of Preferred Stock will be issued and outstanding.; selected security: common stock; selected scenario: as disclosed; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 6 row 5 columns 2; share summary; label column 1; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1 ↗

Basis and evidence 2

Prospectus share summary; Number of shares of common stock outstanding before the offering of common stock; 200,000,000 shares of Common stock.; selected security: Common stock; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 6 row 4 columns 2; share summary; label column 1; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1 ↗

Basis and evidence 3

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value.

Primary common-share offering summary; Securities Being Offered: 10,000,000 Common Shares, par value $0.0001 per share.; Offering price per share: We will sell the shares at a fixed price of $5.00 per share for the duration of this Offering.; proposed terms as printed; no security conversion, inferred proceeds or equity value. Figures retain their stated source scenario and conditions.

Exact input · Fixed offering price per common share: $5

SEC table 6 row 2 columns 2; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1; vertical offering context cells 1:2,2:2,3:2 ↗

SEC table 6 row 3 columns 2; source 46217:50836; SHA256 1bf76e25c4621f209a65b378a37cad822d58d511fa0d6b0d6180c5c9831a4cd1; vertical offering context cells 1:2,2:2,3:2 ↗

Share-count comparison

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Base post-offer shares

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Equity value

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Share-count change

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Alternative scenarios

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Sensitivity

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-08-31
!Harmony Medical Group Limited owns 200,000,000 shares, representing 100% before the offering, and controls all voting power. If all offered shares are sold, it would own approximately 95.24% based on the stated 210,000,000 post-offering shares, although the ownership table does not provide the after-offering percentage.View source ↗
Relationship filters
Show
ownership / voting rights
share structure
Select for details · La Beaute Inc.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
Harmony Medical Group LimitedBeneficial ownership—100%Beneficial—
Percentage of Ownership before OfferingDisclosedEvidence
Harmony Medical Group LimitedBeneficial shares200,000,000——
Common Stock Owned before OfferingDisclosedEvidence
Common Stockper-share voting rights——1 vote per shareVotes per share
Literal source per-share voting entitlement; Common Stock; full source conditions retained; not a holder voting percentage, ownership amount or controller findingDisclosedEvidence
Source and calculation ↗
Harmony Medical Group Limited · Harmony Medical Group Limited — Beneficial ownership · 100%

Exact source ownership column: Percentage of Ownership before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Ownership before Offering; source holder: Harmony Medical Group Limited

0002151905-26-000001 · SEC table 13 row 2 columns 4; source 217944:220053; SHA256 62ec0d344f27d47cdc33eba25aaf5838ea610e28f1a4b9725f5432ba9eda2023; ownership header cells 1:4 ↗

Harmony Medical Group Limited · Harmony Medical Group Limited — Beneficial shares · 200,000,000

Exact source ownership column: Common Stock Owned before Offering; holders may overlap; not an additive partition

Raw source column: Common Stock Owned before Offering; source holder: Harmony Medical Group Limited

0002151905-26-000001 · SEC table 13 row 2 columns 2; source 217944:220053; SHA256 62ec0d344f27d47cdc33eba25aaf5838ea610e28f1a4b9725f5432ba9eda2023; ownership header cells 1:2 ↗

Common Stock · Common Stock — per-share voting rights · 1 vote per share

Literal source per-share voting entitlement; Common Stock; full source conditions retained; not a holder voting percentage, ownership amount or controller finding

Each holder of shares of Common Stock is entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. Cumulative voting rights do not apply to Common Stock. Additionally, holders of any class or series of stock do not have preemptive rights to subscribe for, purchase, or receive any new or additional issuances of shares or convertible securities, regardless of whether such issuances are authorized now or in the future, or whether they are issued for money, for consideration other than money, or as a dividend.

0002151905-26-000001 · SEC ownership paragraph; source 161017:161657; SHA256 e0e0ac941a7d19954a02f70d69b3322f861565d7dcce2f5d8de037a4c34f4e79 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Source lock-up conditions

Literal month restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
Our directors, executive officers, and shareholdersAfter date of this prospectus · Source conditions apply6 months
Source and calculation
Our directors, executive officers, and shareholders

Our directors, executive officers, and shareholders have entered into agreements, subject to limited exceptions, not to offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise dispose of, directly or indirectly, any of our Common stock or other securities for a period of six months from the date of this prospectus. This includes refraining from entering into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of such securities without the prior written consent of the representative. Additionally, the Company is prohibited from conducting any offerings during this period and from re-pricing or changing the terms of existing options and warrants.

SEC lock-up paragraph; source 171083:171997; SHA256 6f99e87588164e58fd26bf2a99221e64fb26957b2156f41b95d67ccce215eda0 ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

date of this prospectus

  1. Our directors, executive officers, and shareholdersOur directors, executive officers, and shareholders have entered into agreements, subject to limited exceptions, not to offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise dispose of, directly or indirectly, any of our Common stock or other securities for a period of six months from the date of this prospectus. This includes refraining from entering into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of such securities without the prior written consent of the representative. Additionally, the Company is prohibited from conducting any offerings during this period and from re-pricing or changing the terms of existing options and warrants.
Holder / event
Holder / eventTerm / dateConditions
Our directors, executive officers, and shareholders6 monthsOur directors, executive officers, and shareholders have entered into agreements, subject to limited exceptions, not to offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise dispose of, directly or indirectly, any of our Common stock or other securities for a period of six months from the date of this prospectus. This includes refraining from entering into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of such securities without the prior written consent of the representative. Additionally, the Company is prohibited from conducting any offerings during this period and from re-pricing or changing the terms of existing options and warrants.
Basis and evidence
Our directors, executive officers, and shareholders

Our directors, executive officers, and shareholders have entered into agreements, subject to limited exceptions, not to offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise dispose of, directly or indirectly, any of our Common stock or other securities for a period of six months from the date of this prospectus. This includes refraining from entering into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of such securities without the prior written consent of the representative. Additionally, the Company is prohibited from conducting any offerings during this period and from re-pricing or changing the terms of existing options and warrants.

SEC lock-up paragraph; source 171083:171997; SHA256 6f99e87588164e58fd26bf2a99221e64fb26957b2156f41b95d67ccce215eda0 ↗

The draft leaves cash, assets, revenue and loss amounts blank. Nearby no-loss wording does not supply those amounts.

Financial quality

Financial quality
CalculationReported valueReference
Total assetsBlank in the filed draftAs of July 31, 2026
Cash and cash equivalentsBlank in the filed draftAs of July 31, 2026
RevenueBlank in the filed draftFor the year ended July 31, 2026
Net income / (loss)Blank in the filed draftFor the period ended July 31, 2026
Working capital / (deficit)Blank in the filed draftFor the period ended July 31, 2026
Source and limits

These source states do not establish other financial fields or a zero balance.

The draft also contains separate financial claims. They have not been reconciled into reported figures.

As of July 31, 2026, we had total assets of $[ ] and cash and cash equivalents of $[ ].

0002151905-26-000001 · 121341:121478 · SHA256 79a2a636b1ca6a2b5808e75896b4e6bd9b665c7b888589ee9d767e59383b9e56 ↗

For the year ended July 31, 2026, we realized revenues of $[ ], and a gross profit of $[ ].

0002151905-26-000001 · 122027:122169 · SHA256 277698e2f3059e3f5676dfcf7924f8987908c317c3cc0abd091409fc78ea3346 ↗

The financial statements included herein have been prepared on the assumption that the Company will continue as a going concern. For the period ended July 31, 2026, the Company recorded a net loss of $[ ], which led to an accumulated deficit of $[ ] and a working capital of $[ ].

0002151905-26-000001 · 124382:124720 · SHA256 f67cebc46a5b81f32afcda8822b187ac8bfe0175df23fb7a74e15b282c39783c ↗

As of July 31, 2026, we have no liabilities. We have a shareholders’ equity of $[ ].

121700:121840 · SHA256 7ac9d5572405c9f497675b65ce240c3fd4e851bb8388c06e7cc5a997dab66b70 ↗
Financial quality and runway
Financial review

Financial quality and runway

The supplied evidence does not provide reliable complete financial amounts. The filing states no liabilities and no net loss for the year ended July 31, 2026, but key amounts remain placeholders and the company discloses substantial doubt about continuing as a going concern.

EvidenceFinancial review 1

Assets, cash, revenue, gross profit, SG&A, cash flows and equity amounts are blank.

Source · MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONN AND RESULTS OF OPERATIONSOpen S-1 ↗
EvidenceFinancial review 2

The filing states substantial doubt about going concern within one year from issuance of the financial statements.

LATEST COMPARISON

Baseline filing — comparison pending

No source-comparable material changes identified in this report.

Open S-1 ↗

No source-comparable material changes identified in this report.

IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 2

The company states that investors may lose their entire investment and that subscription funds generally are non-refundable after acceptance.

DocumentS-10002151905-26-000001
Filed2026-08-31SEC EDGAR
Research updated2026-09-07Analysed
Source-bound table inputs6SEC EDGAR
Open filing ↗